Dr. Kraft is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1364 Clifton Rd NE
F145C
Atlanta, GA 30322Phone+1 404-712-8889
Summary
- Dr. Colleen Kraft is an infectious disease specialist in Atlanta, GA. She received her medical degree from Indiana University School of Medicine and has been in practice 15 years. She specializes in microbiology and is experienced in ebola, staphylococcus, clinical microbiology, viruses, and pandemic. She has more than 100 publications and over 500 citings.
Education & Training
- Emory UniversityM.S., Clinical Research, 2011 - 2013
- Emory University School of MedicineFellowship, Medical Microbiology, 2009 - 2010
- Emory University School of MedicineFellowship, Infectious Disease, 2005 - 2009
- Emory University School of MedicineResidency, Internal Medicine, 2002 - 2005
- Indiana University School of MedicineClass of 2002
- Taylor UniversityB.A., Biology, Magna cum laude, 1994 - 1998
Certifications & Licensure
- GA State Medical License 2003 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
- American Board of Pathology Pathology - Medical Microbiology
Awards, Honors, & Recognition
- Funds for Innovative Teaching (FIT) Award, “Virtual Microbiology Rounds: A tool to extend teaching clinical microbiology and infectious diseases pathology to healthcare trainees at Emory remote sites” (Eileen Burd, Jesse Jacob co-awardees) Emory University, 2013
- Award recipient, Loan Repayment Program NIH, 2012
- Funds for Innovative Teaching (FIT) Award, “Computerization of microbiology vignettes as a tool to teach microbiology and infectious diseases pathology to healthcare professionals” (Jeannette Guarner, Eileen Burd co-awardees) Emory University, 2009
- Join now to see all
Clinical Trials
- FMT in Ulcerative Colitis-Associated Pouchitis Start of enrollment: 2014 Jul 01
- Mucosal Versus Fecal Microbiota in FMT Start of enrollment: 2014 Apr 01
- FMT for MDRO Colonization After Infection in Renal Transplant Recipients Start of enrollment: 2016 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsThe Need for Dedicated Microbiology Leadership in the Clinical Microbiology LaboratoryLinoj Samuel, Glen Hansen, Colleen S. Kraft, Bobbi S. Pritt
Journal of Clinical Microbiology. 2021-02-17 - 33 citationsSafety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Sin...Matthew D Sims, Sahil Khanna, Paul Feuerstadt, Thomas J Louie, Colleen R Kelly
JAMA Network Open. 2023-02-01 - 8 citationsPrevalence of Comorbid Factors in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota-Based Therapeutic.Charles S Berenson, Bret Lashner, Louis Y Korman, Elizabeth Hohmann, Abhishek Deshpande
Clinical Infectious Diseases. 2023-11-30
Journal Articles
- Polymicrobial ventriculitis involving Pseudomonas fulvaRebolledo P, Vu CL, Carlson R, Kraft CS, Anderson E, Burd E, J Clin Microbiol, 6/1/2014
- Development of oxacillin resistance in a patient with recurrent Staphylococcus aureus bacteremiaBurd E, Alam M, Passalacqua K, Kalokhe A, Eaton M, Satola S, Kraft C, and Read T, J Clin Microbiol, 5/21/2014
- Mycobacterium paraffinicum causing symptomatic pulmonary infectionChan AW, Kabbani S, Staton G, Kraft CS, J Clin Microbiol, 4/1/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Comparative detection of Staphylococcus aureus genotypic data between blood culture broth and subcultured isolatesKraft CS, Alam T, Petit RA, Crispell EK, Satola SW, Read TD, ASM, 113th General Meeting, Denver, CO, 5/1/2013
- Development of a supervised learning algorithm to distinguish VISA from VSSA in clinical samplesKraft CS, Rishishwar L, Jordan IK, ASM, 113th General Meeting, Denver, CO, 5/1/2013
- Investigation of cefoxitin-oxacillin discrepancies in clinical isolates of Staphylococcus aureus using Next Gen sequencingKraft CS, Petit RA, Rossi MR, Read TR, Burd EM, ASM, 112th General Meeting, San Francisco, CA, 6/1/2012
- Join now to see all
Lectures
- Laboratory Detection of Multi-drug resistant organismsCali, Colombia - 6/1/2014
- Fecal Microbiota Transplantataion: From Practical to Practice to PromiseBoston, MA - 5/1/2014
- Point-Counterpoint: Practical considerations for implementation of Fecal Microbiota TransplantBoston, MA - 5/1/2014
- Join now to see all
Press Mentions
- Lessons from Treating Ebola Patients Lead to Emory’s New Healthcare Test Kitchen LabOctober 18th, 2024
- Building Metabolically Stable and Potent Anti-HIV Thioether-Lipid Analogues of Tenofovir Exalidex: A Thorough Pharmacological AnalysisOctober 16th, 2024
- Research Roundup: Recent Grants and Publications for Emory Faculty and StaffMarch 10th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: